The latest closing stock price for Cue Biopharma as of June 13, 2025 is 0.60.
An investor who bought $1,000 worth of Cue Biopharma stock at the IPO in 2018 would have $-948 today, roughly -1 times their original investment - a -34.49% compound annual growth rate over 7 years.
The all-time high Cue Biopharma stock closing price was 30.73 on June 02, 2020.
The Cue Biopharma 52-week high stock price is 1.99, which is 231.7% above the current share price.
The Cue Biopharma 52-week low stock price is 0.45, which is 25% below the current share price.
The average Cue Biopharma stock price for the last 52 weeks is 1.00.
An investor who bought $1,000 worth of Cue Biopharma stock at the IPO in 2018 would have $-948 today, roughly -1 times their original investment - a -34.49% compound annual growth rate over 7 years.
The all-time high Cue Biopharma stock closing price was 30.73 on June 02, 2020.
The Cue Biopharma 52-week high stock price is 1.99, which is 231.7% above the current share price.
The Cue Biopharma 52-week low stock price is 0.45, which is 25% below the current share price.
The average Cue Biopharma stock price for the last 52 weeks is 1.00.